MHRA Inspection Readiness: How to Pass First Time

An MHRA GCP inspection is not a pop quiz. It's a structured assessment of your trial management systems, and with the right preparation, it should be entirely uneventful. The sponsors who struggle are the ones who treat inspection readiness as a last-minute scramble rather than an ongoing discipline.

Here's what actually matters when the inspector calls.

What the MHRA Actually Looks For

MHRA inspectors operate against a clear framework. They're not fishing — they have specific systems to evaluate:

• Trial Master File (TMF) completeness and quality — Is every essential document present, version-controlled, and correctly filed? Can you locate any document within 30 seconds?
• Investigator oversight — Is the PI genuinely supervising the trial, or just signing forms?
• Informed consent process — Are consent forms ICH-GCP compliant? Is the consent process documented properly?
• Safety reporting — Are SAEs reported within regulatory timelines? Is the pharmacovigilance process documented?
• Data management and query resolution — Is there an audit trail for all data changes?
• Delegation log accuracy — Does the delegation log match who's actually doing what?

The most common Major finding from MHRA inspections is incomplete TMF documentation. Not fraud. Not misconduct. Just paperwork gaps that could have been caught by a regular quality check.

The 90-Day TMF Audit

If you're not auditing your TMF at least every 90 days, you're not inspection-ready. Here's what a proper TMF audit covers:

1. Completeness Check

Compare your TMF index against the actual file. Flag every missing document. The TMF Reference Model (TMF RM) provides a good baseline, but your index should be tailored to your protocol.

2. Filing Quality

Every document should be:

• Filed in the correct zone and section
• A clear, legible scan (not a blurry photo)
• Version-controlled with dates and signatures visible
• Named consistently (don't mix "ICF_v3" with "informed_consent_FINAL_FINAL")

3. Cross-Reference Integrity

Do your delegation log, signature log, and training records tell the same story? Inspectors check for inconsistencies between documents. If the delegation log says Dr. Smith handles SAE reporting but the training file shows no PV training, that's a finding.

Common Findings That Sink Sponsors

Based on published MHRA inspection reports, these are the recurring issues:

• Missing essential documents — Protocol amendments filed late, missing ethics approval letters, unsigned pages
• Outdated delegation logs — Staff changes not reflected, tasks delegated to people no longer at the site
• Inadequate PI oversight — PI signature on documents they clearly didn't review (dating errors, signing for events that hadn't happened yet)
• Poor SAE reporting timelines — The 24-hour rule for unexpected serious adverse reactions is non-negotiable
• Data query backlog — Unresolved queries older than 30 days suggest a broken data management process

Building Inspection-Ready Systems

The goal isn't to prepare for an inspection — it's to run your trial in a way that you're always inspection-ready. This means:

Real-Time TMF Management

Documents should be filed within 48 hours of generation. Not at the end of the month. Not before the monitoring visit. Within 48 hours. AI-assisted TMF quality checks can flag missing documents, naming inconsistencies, and version conflicts automatically.

Automated Quality Metrics

Track these weekly:

• TMF completeness percentage
• Open query age (average and maximum)
• SAE reporting compliance rate
• Delegation log currency (days since last update)

Regular Mock Inspections

Every 6 months, run an internal mock inspection. Use the MHRA's own inspection template. Have someone who isn't running the trial conduct it. Document findings and close them within 30 days.

The Week Before: Final Checklist

• ✅ All essential documents filed and QC'd
• ✅ Delegation log current and signed
• ✅ Training records up to date for all staff
• ✅ SAE log complete with timeline compliance documented
• ✅ Query backlog cleared (zero queries >30 days)
• ✅ Site staff briefed on inspection process
• ✅ Room booked for inspector with document access
• ✅ Key contacts identified and available

What DEOX Does Differently

We build inspection readiness into daily operations, not pre-inspection panic. Our QMS includes 30+ SOPs covering every aspect of GCP compliance. AI-assisted TMF monitoring flags issues before they become findings. And because our teams are senior-led — not layered with junior CRAs — the people managing your trial actually understand what inspectors are looking for.

DEOX Clinical provides lean, sponsor-sided clinical trial management for UK biotech teams. Inspection-ready from day one.